Clinical Trial Update: Combination of Netupitant and Palonosetron (Akynzeo®) in the Treatment of Refractory CINV [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a combination of netupitant and palonosetron (Akynzeo) for refractory chemotherapy-induced nausea and vomiting has been terminated, w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Akynzeo (netupitant/palonosetron)

Snippet

Sponsor: Joseph Ma | Conditions: Chemotherapy Induced Nausea Vomiting | Phase 2 | Status: TERMINATED | Results posted: 2019-05-09